(Press-News.org) Laughter may be as effective as eye drops in improving symptoms of dry eye disease, finds a clinical trial from China published by The BMJ today
The researchers suggest that laughter exercise could be an initial treatment for relieving symptoms of dry eye disease.
Dry eye disease (DED) is a chronic condition estimated to affect around 360 million individuals worldwide. Common symptoms include uncomfortable, red, scratchy or irritated eyes.
Evidence suggests that laughter therapy alleviates depression, anxiety, stress, and chronic pain, while strengthening immune function and is recognised as a beneficial complementary and add-on treatment for various chronic conditions, including mental health disorders, cancer, and diabetes. But whether laughter therapy has a beneficial effect on dry eye disease is still unknown.
To explore this further, researchers from China and the UK set out to assess the effectiveness and safety of laughter exercise in patients with symptoms of dry eye disease.
Their findings are based on 283 participants aged 18-45 years (average age 29; 74% female) who were assessed for dry eye disease using the ocular surface disease index (OSDI) score and randomly assigned to receive laughter exercise or 0.1% sodium hyaluronic acid eye drops four times a day for eight weeks.
Participants with existing eye conditions, injury, infection or allergy, and those who had recently used contact lenses or any dry eye disease treatment were excluded.
The laughter exercise group watched an instructional video and were asked to vocalise and repeat the phrases “Hee hee hee, hah hah hah, cheese cheese cheese, cheek cheek cheek, hah hah hah hah hah hah” 30 times per five minute session using a face recognition mobile app to standardise the exercise and enhance facial movements.
The eye drop (control) group applied 0.1% sodium hyaluronic acid eye drops to both eyes four times a day for eight weeks, tracking their usage frequency via the same app.
Both treatments were stopped at eight weeks and any change in eye surface discomfort scores were measured at weeks 10 and 12.
The average OSDI score at eight weeks was 10.5 points lower (indicating less discomfort) in the laughter exercise group and 8.83 lower in the control group, with a mean difference of −1.45 points, suggesting that laughter exercise was no less effective than eye drops.
Laughter exercise also showed significant improvements in non-invasive tear break up time (time taken for the first dry spot to appear on the cornea after a blink), meibomian gland function (oil glands that help prevent tears from evaporating too quickly), and mental health scores. No adverse events were noted in either study group.
The authors acknowledge some limitations that may have influenced the results, but say the findings suggest that laughter exercise was non-inferior to 0.1% sodium hyaluronic acid in improving dry eye disease symptoms and clinical signs.
“As a safe, environmentally friendly, and low cost intervention, laughter exercise could serve as a first-line, home based treatment for people with symptomatic dry eye disease and limited corneal staining,” they add.
[Ends]
END
Laughter may be as effective as drops for dry eyes
Researchers suggest this could be a first treatment for relieving symptoms of dry eye disease
2024-09-11
ELSE PRESS RELEASES FROM THIS DATE:
Path to prosperity for planet and people if Earth’s critical resources are better shared: report
2024-09-11
Earth will only remain able to provide even a basic standard of living for everyone in the future if economic systems and technologies are dramatically transformed and critical resources are more fairly used, managed and shared, according to an international research team including scientists from The Australian National University (ANU).
The report, published in The Lancet Planetary Health, outlines how cities and businesses have the power to play a crucial role and become the “stewards” of critical Earth ...
Long-course radiotherapy is better than short-course for organ preservation in rectal cancer
2024-09-11
The COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given before surgery may be a better treatment for avoiding surgery, preserving the rectum and anus, and preventing regrowth of the primary tumour than a short course of radiotherapy for patients with rectal cancer – a type of bowel cancer. However, the overall survival and survival free of recurrence of the disease remained the same for both treatments.
These findings are from a new study published in ...
Large-scale population analysis confirms reassuring safety profile of tirzepatide
2024-09-11
As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged. Now real-world evidence from the FDA Adverse Event Reporting System (FAERS) database reveals a reassuring safety profile for tirzepatide (TZP).
The findings to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), and published in the The Journal of Endocrinological Investigation (link below) reveal that, compared to the widely used class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), TZP has similar gastrointestinal ...
Tirzepatide associated with greater weight loss in women than men
2024-09-11
All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).
The post hoc analysis, which included the four SURMOUNT trials [1], compared tirzepatide with a placebo for up to 72 to 88 weeks in 4,677 adults (2,999 females, 1,678 males) living with obesity, highlighting potential sex differences in the response.
Tirzepatide, a once-weekly glucose-dependent ...
Rapid control of blood sugar levels in women with gestational diabetes can reverse the risk of their children developing obesity, US study finds
2024-09-11
Swiftly achieving glycaemic control after a diagnosis of gestational diabetes can bring the baby’s risk obesity in childhood down to a level similar to that of children whose mothers did not have gestational diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), has found.
Gestational diabetes, a type of diabetes that can develop during pregnancy, affects 14% of pregnant women globally and is becoming more common, with those who are living with obesity, have a family ...
Semaglutide’s cardiovascular benefits are maintained in people with impaired kidney function
2024-09-11
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don’t have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).
The results are based on a pre-specified analysis of the SELECT trial which found that adults with overweight or obesity but not diabetes taking semaglutide for more than 3 years had a 20% lower risk of MACE or ...
Study reveals key predictors for achieving and sustaining blood glucose control and weight loss with tirzepatide in adults with type 2 diabetes
2024-09-11
The phase 3 SURPASS-4 trial published in 2021 established that tirzepatide lowers blood sugar and supports weight loss better than insulin glargine (a long-acting insulin) for type 2 diabetes (T2D) [1]. Now new research examining a broad range of potential predictors of sustaining blood sugar control and weight loss indicates that greater weight loss, better β-cell function, and a greater decrease in low-density lipoprotein cholesterol (LDL-C or “bad cholesterol”) during the first year of tirzepatide therapy are the most ...
Avian flu found in wastewater of 10 Texas cities through virome sequencing by researchers at UTHealth Houston and Baylor College of Medicine
2024-09-11
Avian influenza A(H5N1) virus, which spread to cattle and infected 14 people this year, was detected using virome sequencing in the wastewater of 10 Texas cities by researchers at UTHealth Houston and Baylor College of Medicine. The virome is the collection of viruses in a sample, in this case a wastewater sample.
The information was published in the New England Journal of Medicine.
Until March 2024, H5N1 had not been detected in 1,337 wastewater samples analyzed by the team. But from March 4 to July 15 (the end of data collection for this article), H5N1 was ...
Culturing muscle cells
2024-09-11
Harvard stem cell biologists have pioneered a groundbreaking 3D organoid culture method for generating large numbers of adult skeletal muscle satellite cells, also known as muscle stem cells, in vitro.
The ability to efficiently make functional muscle stem cells in this way is expected to accelerate understanding of and treatments for disorders of skeletal muscle, including those that are neuromuscular in origin. The new technique, detailed in Nature Biotechnology, also provides a powerful tool for studying muscle biology.
"People will be able to do all these engraftment and regeneration experiments because suddenly, you have millions of cells,” said co-author and Harvard research ...
ORNL debuts convergent manufacturing platform at IMTS 2024
2024-09-11
A new convergent manufacturing platform, developed in only five months at the Department of Energy’s Oak Ridge National Laboratory, is debuting at the International Manufacturing Technology Show, or IMTS, in Chicago, Sept. 9–12, 2024.
The technology, called Future Foundries, opens the door for hundreds of thousands of small- and medium-sized companies to join the convergent manufacturing revolution, according to ORNL researchers. It is a cutting-edge platform that integrates multiple advanced manufacturing systems into a single, agile platform.
“The democratization ...
LAST 30 PRESS RELEASES:
American College of Cardiology, OpenEvidence to advance AI-enabled, evidence-based cardiovascular care
OHSU researchers develop promising drug for aggressive breast cancer
Evaluating the potential of a sleep intervention among youth at high-risk for borderline personality disorder
Saturn’s icy moon may host a stable ocean fit for life, study finds
More children, shorter lifespan? Clear evidence from the Great Finnish Famine
Climate intervention techniques could reduce the nutritional value of crops
Mapping resilient supply solutions for graphite, a critical mineral powering energy storage: Rice experts’ take
Effects of sodium glucose cotransporter 2 inhibitors by diabetes status and level of albuminuria
Young people using unregulated nicotine pouches despite health risks
New study finds family and caregivers can help spot post-surgery delirium early
High-impact clinical trials generate promising results for improving kidney health - part 2
More Americans are on dialysis. Could more safely wean off it?
A conservative dialysis strategy and kidney function recovery in dialysis-requiring acute kidney injury
More Americans, especially Black adults, are dying before they can access Medicare benefits
Death Valley plant reveals blueprint for building heat-resilient crops
Racial disparities in premature mortality and unrealized Medicare benefits across US states
Heat- and cold-related mortality burden in the US from 2000 to 2020
Research hints at the potential of pain relief with CBD
Dr. Johnson V. John appointed as a Standing Member of the NIH Musculoskeletal Tissue Engineering (MTE) Study Section
TCF/LEF transcription factors emerge as druggable targets in Wnt signaling, offering new hope for fibrosis and cancer therapies
New alloy design could power solid-state batteries that charge faster and last longer
Discovery to display: FAU unveils the ‘Art of Science’ winners
Achieving electrocatalytic activity toward oxygen reduction reaction based on Ruddlesden-Popper type cathode catalyst for solid oxide fuel cells
Ceramic-based electromagnetic interference shielding materials: mechanisms, optimization strategies, and pathways to next-generation applications
NIH-funded exploratory study to seek possible targets for treating alcohol use disorder
Hanyang University researchers develop of novel high-resolution mechanoluminescent platform technology
Hidden HPV-linked cell type may drive early cervical cancer, scientists report
Metros cut car use in European cities, but trams fall short
Antarctic ice melt triggers further melting: Evidence for cascading feedbacks 9,000 years ago
Colorectal cancer evades immunotherapy using a dual barrier
[Press-News.org] Laughter may be as effective as drops for dry eyesResearchers suggest this could be a first treatment for relieving symptoms of dry eye disease



